Transforming growth factor-β signaling in tumor initiation, progression and therapy in breast cancer: an update
Authors:
- 16 August 2011
- journal article
- review article
- Published by Springer Nature in Cell and tissue research
- Vol. 347 (1) , 73-84
Abstract
Transforming growth factor-β (TGF-β) is a ubiquitous cytokine playing an essential role in cell proliferation, differentiation, apoptosis, adhesion and invasion, as well as in cellular microenvironment. In malignant diseases, TGF-β signaling features a growth inhibitory effect at an early stage but aggressive oncogenic activity at the advanced malignant state. Here, we update the current understanding of TGF-β signaling in cancer development and progression with a focus on breast cancer. We also review the current approaches of TGF-β signaling-targeted therapeutics for human malignancies.Keywords
This publication has 126 references indexed in Scilit:
- TGF-β and immune cells: an important regulatory axis in the tumor microenvironment and progressionTrends in Immunology, 2010
- Cathepsin G-mediated enhanced TGF-β signaling promotes angiogenesis via upregulation of VEGF and MCP-1Cancer Letters, 2010
- Mammary tumor heterogeneity in the expansion of myeloid-derived suppressor cellsInternational Immunopharmacology, 2009
- Transforming growth factor-β signaling: emerging stem cell target in metastatic breast cancer?Breast Cancer Research and Treatment, 2008
- TGFβ in CancerCell, 2008
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem CellsCell, 2008
- TGF‐β signaling: A tale of two responsesJournal of Cellular Biochemistry, 2007
- Regulation of Smad activitiesBiochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 2006
- Transforming growth factor-β in cancer and metastasisCancer and Metastasis Reviews, 2006
- Smad-dependent and Smad-independent pathways in TGF-β family signallingNature, 2003